Skip to content
OpenCapital
Get started

Teleflex TFX EMEA — Research and development expenses

Other segment segments

Americas
$14.25M+21.0%
Asia
$3.08M-29.4%

Similar metrics at other companies

Zimmer Biomet Holdings logo
ZBHEMEA — Research And Development Expense Excluding Acquired In Process Cost
$1.7M-19.0%
Vertiv Holdings Co logo
VRTEurope, Middle East, & Africa — Engineering, research and development costs
$23M-1.3%
Watts Water Technologies, Inc. logo
WTSEurope — Research And Development Expense
$3M+30.4%
SSD
SSDEurope — Research And Development And Other Engineering Expense
$2.55M+19.7%
Becton, Dickinson and Company logo
BDXMedical Essentials — Research and development expense
$53M+10.4%
AGCO logo
AGCOEurope/Middle East — Engineering expenses
$80.2M+14.6%

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%—

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's emea — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's EMEA — research and development expenses?
Teleflex (TFX) reported EMEA — research and development expenses of $24.5M in Q1 2026.
How has Teleflex's EMEA — research and development expenses changed year-over-year?
Teleflex's EMEA — research and development expenses increased by 256.5% year-over-year, from $6.87M to $24.5M.
What is the long-term trend for Teleflex's EMEA — research and development expenses?
Over 3 years (2022 to 2025), Teleflex's EMEA — research and development expenses has grown at a -3.3% compound annual growth rate (CAGR), from $69.82M to $63.22M.
What does EMEA — research and development expenses mean?
Captures the investment in innovation and product development specifically allocated to the EMEA segment's portfolio. These expenditures support the creation of new medical technologies and the improvement of existing product lines to maintain market relevance. Higher investment levels often signal a commitment to long-term product pipeline growth and competitive differentiation.